126 related articles for article (PubMed ID: 20951036)
1. Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity.
Hadden M; Deering DM; Henderson AJ; Surman MD; Luche M; Khmelnitsky Y; Vickers S; Viggers J; Cheetham S; Guzzo PR
Bioorg Med Chem Lett; 2010 Dec; 20(23):7020-3. PubMed ID: 20951036
[TBL] [Abstract][Full Text] [Related]
2. 5-(pyridinon-1-yl)indazoles and 5-(furopyridinon-5-yl)indazoles as MCH-1 antagonists.
Surman MD; Freeman EE; Grabowski JF; Hadden M; Henderson AJ; Jiang G; Jiang XM; Luche M; Khmelnitsky Y; Vickers S; Viggers J; Cheetham S; Guzzo PR
Bioorg Med Chem Lett; 2010 Dec; 20(23):7015-9. PubMed ID: 20961756
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrocarboline analogs as MCH-1 antagonists.
Henderson AJ; Deering D; Grabowski JF; Hadden M; Jiang X; Khmelnitsky Y; Luche M; Surman MD; Cheetham S; Vickers S; Viggers J; Guzzo PR
Bioorg Med Chem Lett; 2010 Dec; 20(23):7024-8. PubMed ID: 20952195
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR study of pyrrolo[3,4-b]pyridin-7(6H)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists.
Lim CJ; Kim JY; Lee BH; Oh KS; Yi KY
Bioorg Med Chem Lett; 2013 Mar; 23(6):1736-9. PubMed ID: 23411080
[TBL] [Abstract][Full Text] [Related]
5. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice.
Ito M; Ishihara A; Gomori A; Egashira S; Matsushita H; Mashiko S; Ito J; Ito M; Nakase K; Haga Y; Iwaasa H; Suzuki T; Ohtake N; Moriya M; Sato N; MacNeil DJ; Takenaga N; Tokita S; Kanatani A
Eur J Pharmacol; 2009 Dec; 624(1-3):77-83. PubMed ID: 19836369
[TBL] [Abstract][Full Text] [Related]
6. Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.
Kasai S; Kamaura M; Kamata M; Aso K; Ogino H; Nakano Y; Watanabe K; Kaisho T; Tawada M; Nagisa Y; Takekawa S; Kato K; Suzuki N; Ishihara Y
Bioorg Med Chem; 2011 Nov; 19(21):6261-73. PubMed ID: 21975069
[TBL] [Abstract][Full Text] [Related]
7. Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity.
Souers AJ; Gao J; Brune M; Bush E; Wodka D; Vasudevan A; Judd AS; Mulhern M; Brodjian S; Dayton B; Shapiro R; Hernandez LE; Marsh KC; Sham HL; Collins CA; Kym PR
J Med Chem; 2005 Mar; 48(5):1318-21. PubMed ID: 15743174
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
Rowbottom MW; Vickers TD; Tamiya J; Zhang M; Dyck B; Grey J; Schwarz D; Heise CE; Hedrick M; Wen J; Tang H; Wang H; Fisher A; Aparicio A; Saunders J; Goodfellow VS
Bioorg Med Chem Lett; 2007 Apr; 17(8):2171-8. PubMed ID: 17350839
[TBL] [Abstract][Full Text] [Related]
9. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
Wu WL; Burnett DA; Caplen MA; Domalski MS; Bennett C; Greenlee WJ; Hawes BE; O'Neill K; Weig B; Weston D; Spar B; Kowalski T
Bioorg Med Chem Lett; 2006 Jul; 16(14):3674-8. PubMed ID: 16690315
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
Mihalic JT; Chen X; Fan P; Chen X; Fu Y; Liang L; Reed M; Tang L; Chen JL; Jaen J; Li L; Dai K
Bioorg Med Chem Lett; 2011 Dec; 21(23):7001-5. PubMed ID: 22019296
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.
Kasai S; Kamata M; Masada S; Kunitomo J; Kamaura M; Okawa T; Takami K; Ogino H; Nakano Y; Ashina S; Watanabe K; Kaisho T; Imai YN; Ryu S; Nakayama M; Nagisa Y; Takekawa S; Kato K; Murata T; Suzuki N; Ishihara Y
J Med Chem; 2012 May; 55(9):4336-51. PubMed ID: 22490048
[TBL] [Abstract][Full Text] [Related]
14. Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.
Yan L; Huo P; Debenham JS; Madsen-Duggan CB; Lao J; Chen RZ; Xiao JC; Shen CP; Stribling DS; Shearman LP; Strack AM; Tsou N; Ball RG; Wang J; Tong X; Bateman TJ; Reddy VB; Fong TM; Hale JJ
J Med Chem; 2010 May; 53(10):4028-37. PubMed ID: 20423086
[TBL] [Abstract][Full Text] [Related]
15. Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases.
Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar BD; Weig B
Bioorg Med Chem Lett; 2006 Oct; 16(20):5427-31. PubMed ID: 16889961
[TBL] [Abstract][Full Text] [Related]
16. 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1).
Lim CJ; Kim SH; Lee BH; Oh KS; Yi KY
Bioorg Med Chem Lett; 2012 Jan; 22(1):427-30. PubMed ID: 22137790
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists.
Ma V; Bannon AW; Baumgartner J; Hale C; Hsieh F; Hulme C; Rorrer K; Salon J; van Staden C; Tempest P
Bioorg Med Chem Lett; 2006 Oct; 16(19):5066-72. PubMed ID: 16887348
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
[TBL] [Abstract][Full Text] [Related]
19. The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.
Hertzog DL; Al-Barazanji KA; Bigham EC; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Daniels AJ; Garrido DM; Goetz AS; Grizzle MK; Guo YC; Handlon AL; Ignar DM; Morgan RO; Peat AJ; Tavares FX; Zhou H
Bioorg Med Chem Lett; 2006 Sep; 16(18):4723-7. PubMed ID: 16870432
[TBL] [Abstract][Full Text] [Related]
20. Identification of melanin-concentrating hormone receptor and its impact on drug discovery.
Saito Y; Maruyama K
J Exp Zool A Comp Exp Biol; 2006 Sep; 305(9):761-8. PubMed ID: 16902961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
